Literature DB >> 19218238

Intranuclear degradation of polyglutamine aggregates by the ubiquitin-proteasome system.

Atsushi Iwata1, Yu Nagashima, Lumine Matsumoto, Takahiro Suzuki, Tomoyuki Yamanaka, Hidetoshi Date, Ken Deoka, Nobuyuki Nukina, Shoji Tsuji.   

Abstract

Huntington disease and its related autosomal-dominant polyglutamine (pQ) neurodegenerative diseases are characterized by intraneuronal accumulation of protein aggregates. Studies on protein aggregates have revealed the importance of the ubiquitin-proteasome system as the front line of protein quality control (PQC) machinery against aberrant proteins. Recently, we have shown that the autophagy-lysosomal system is also involved in cytoplasmic aggregate degradation, but the nucleus lacked this activity. Consequently, the nucleus relies entirely on the ubiquitin-proteasome system for PQC. According to previous studies, nuclear aggregates possess a higher cellular toxicity than do their cytoplasmic counterparts, however degradation kinetics of nuclear aggregates have been poorly understood. Here we show that nuclear ubiquitin ligases San1p and UHRF-2 each enhance nuclear pQ aggregate degradation and rescued pQ-induced cytotoxicity in cultured cells and primary neurons. Moreover, UHRF-2 is associated with nuclear inclusion bodies in vitro and in vivo. Our data suggest that UHRF-2 is an essential molecule for nuclear pQ degradation as a component of nuclear PQC machinery in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218238      PMCID: PMC2665101          DOI: 10.1074/jbc.M809739200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Impairment of the ubiquitin-proteasome system by protein aggregation.

Authors:  N F Bence; R M Sampat; R R Kopito
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

2.  Isolation and Characterization of a Novel Human Radiosusceptibility Gene, NP95.

Authors:  Masahiro Muto; Akira Fujimori; Mituru Nenoi; Kazuhiro Daino; Yoichi Matsuda; Asato Kuroiwa; Eiko Kubo; Yasuyoshi Kanari; Makoto Utsuno; Hideo Tsuji; Hideki Ukai; Kazuei Mita; Masahiko Takahagi; Kouichi Tatsumi
Journal:  Radiat Res       Date:  2006-11       Impact factor: 2.841

3.  Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription.

Authors:  T Shimohata; T Nakajima; M Yamada; C Uchida; O Onodera; S Naruse; T Kimura; R Koide; K Nozaki; Y Sano; H Ishiguro; K Sakoe; T Ooshima; A Sato; T Ikeuchi; M Oyake; T Sato; Y Aoyagi; I Hozumi; T Nagatsu; Y Takiyama; M Nishizawa; J Goto; I Kanazawa; I Davidson; N Tanese; H Takahashi; S Tsuji
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

4.  Temporal and spatial localization of novel nuclear protein NP95 in mitotic and meiotic cells.

Authors:  T Uemura; E Kubo; Y Kanari; T Ikemura; K Tatsumi; M Muto
Journal:  Cell Struct Funct       Date:  2000-06       Impact factor: 2.212

5.  Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.

Authors:  Masahisa Katsuno; Hiroaki Adachi; Akito Kume; Mei Li; Yuji Nakagomi; Hisayoshi Niwa; Chen Sang; Yasushi Kobayashi; Manabu Doyu; Gen Sobue
Journal:  Neuron       Date:  2002-08-29       Impact factor: 17.173

6.  Overexpression of NP95 mRNA by tumor promoters in the promotion phase of a two-stage BALB/3T3 cell transformation assay.

Authors:  Ayako Sakai; Yutaka Kikuchi; Masashi Muroi; Tohru Masui; Chie Furihata; Eriko Uchida; Kohsuke Takatori; Ken-Ichi Tanamoto
Journal:  Biol Pharm Bull       Date:  2003-03       Impact factor: 2.233

Review 7.  The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?

Authors:  Christian Bronner; Mayada Achour; Yoshimi Arima; Thierry Chataigneau; Hideyuki Saya; Valérie B Schini-Kerth
Journal:  Pharmacol Ther       Date:  2007-06-22       Impact factor: 12.310

8.  Global changes to the ubiquitin system in Huntington's disease.

Authors:  Eric J Bennett; Thomas A Shaler; Ben Woodman; Kwon-Yul Ryu; Tatiana S Zaitseva; Christopher H Becker; Gillian P Bates; Howard Schulman; Ron R Kopito
Journal:  Nature       Date:  2007-08-09       Impact factor: 49.962

9.  Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions.

Authors:  Astrid Lunkes; Katrin S Lindenberg; Léa Ben-Haïem; Chantal Weber; Didier Devys; G Bernhard Landwehrmeyer; Jean-Louis Mandel; Yvon Trottier
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

10.  Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry.

Authors:  Ian Marc Bonapace; Lucia Latella; Roberto Papait; Francesco Nicassio; Alessandra Sacco; Masahiro Muto; Marco Crescenzi; Pier Paolo Di Fiore
Journal:  J Cell Biol       Date:  2002-06-10       Impact factor: 10.539

View more
  41 in total

Review 1.  How a disordered ubiquitin ligase maintains order in nuclear protein homeostasis.

Authors:  Joel C Rosenbaum; Richard G Gardner
Journal:  Nucleus       Date:  2011-07-01       Impact factor: 4.197

2.  FAT10 protein binds to polyglutamine proteins and modulates their solubility.

Authors:  Yu Nagashima; Hisatomo Kowa; Shoji Tsuji; Atsushi Iwata
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

3.  The Ubiquitin Receptor ADRM1 Modulates HAP40-Induced Proteasome Activity.

Authors:  Zih-Ning Huang; Lu-Shiun Her
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

4.  Differential degradation of full-length and cleaved ataxin-7 fragments in a novel stable inducible SCA7 model.

Authors:  Xin Yu; Abiodun Ajayi; Narasimha Rao Boga; Anna-Lena Ström
Journal:  J Mol Neurosci       Date:  2012-02-25       Impact factor: 3.444

5.  Substrate recognition in nuclear protein quality control degradation is governed by exposed hydrophobicity that correlates with aggregation and insolubility.

Authors:  Eric K Fredrickson; Pamela S Gallagher; Sarah V Clowes Candadai; Richard G Gardner
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

Review 6.  How the nucleus copes with proteotoxic stress.

Authors:  Yoko Shibata; Richard I Morimoto
Journal:  Curr Biol       Date:  2014-05-19       Impact factor: 10.834

7.  The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides.

Authors:  Judith Gillis; Sabine Schipper-Krom; Katrin Juenemann; Anna Gruber; Silvia Coolen; Rian van den Nieuwendijk; Henk van Veen; Hermen Overkleeft; Joachim Goedhart; Harm H Kampinga; Eric A Reits
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

Review 8.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

9.  Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease.

Authors:  Marta Martinez-Vicente; Zsolt Talloczy; Esther Wong; Guomei Tang; Hiroshi Koga; Susmita Kaushik; Rosa de Vries; Esperanza Arias; Spike Harris; David Sulzer; Ana Maria Cuervo
Journal:  Nat Neurosci       Date:  2010-04-11       Impact factor: 24.884

10.  Virus-Induced Chaperone-Enriched (VICE) domains function as nuclear protein quality control centers during HSV-1 infection.

Authors:  Christine M Livingston; Marius F Ifrim; Ann E Cowan; Sandra K Weller
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.